Pharma-Bio Focuses on Supply-Chain Disruptions, Remedies
Pharma-Bio Focuses on Supply-Chain Disruptions, Remedies
August 17, 2022--Researched by Industrial Info Resources (Sugar Land, Texas)--Pharmaceutical supply chains have become more global and complex. With more outsourcing, new modalities, and novel ways to reach patients, it's critical to ensure that pharma supply chains can withstand predicted and unforeseen disruptions. More companies are outsourcing production to contract manufacturers, adding new modalities (such as cell therapy), and exploring novel ways to reach patients. Pharma-biotech supply chains have become increasingly global, complex, and opaque.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- México registra inversiones por 2 mil millones de dólares en el sector farm...
- Mexico Registers US$2 Billion in Pharmaceutical Investments
- New England Sees $27 Billion in Projects Under Construction
- Pharma, Manufacturing Lead Indiana to $21.6 Billion of Projects Under Const...
- India Aims to Reduce Dependence on China for Pharma Market